Renowned breast cancer expert comes to Stanford

MARK PEGRAM, a renowned clinician and scholar in breast cancer research and a leader in translational medicine, has joined the Stanford University Medical Center to direct the breast oncology and molecular therapeutics programs. Pegram began his new position Feb. 1.

As part of the new Women’s Cancer Center clinic, which opened in June, Pegram will help bring newly developed breast cancer therapeutics to clinical trials, conduct his own research and treat patients. “Our goal is to improve our ability to extend the quality and quantity of life for breast cancer patients,” said BEVERLY MITCHELL, director of the Stanford Cancer Institute. “Mark is going to help accomplish this by bringing together excellent clinical care and new approaches to the diagnosis and treatment of breast cancer.”

Read the full announcement on Pegram on the Medical Center’s news website.

— BY BETH MOLE